FDA has 5 weeks until money runs out for approving drugs
Related Articles

Visit the full article


  • FDA approves children’s vaccine for 6 diseases

    KENILWORTH, New Jersey – The U.S. Food and Drug Administration has approved a vaccine for children that guards against multiple diseases. The single shot vaccine is a combination “diphtheria-tetanus-pertussis-hepatitis B-poliomyelitis-invasive haemophilus influenza type B disease” vaccine. Vaxelis is designed for children aged 6 weeks to 4 years old. Sanofi and Merck are now working on the production and supply of Vaxelis. The company reports it won’t be available in the U.S. before 2020. A...


  • FDA approves children’s vaccine for 6 diseases

    KENILWORTH, New Jersey – The U.S. Food and Drug Administration has approved a vaccine for children that guards against multiple diseases. The single shot vaccine is a combination “diphtheria-tetanus-pertussis-hepatitis B-poliomyelitis-invasive haemophilus influenza type B disease” vaccine. Vaxelis is designed for children aged 6 weeks to 4 years old. Sanofi and Merck are now working on the production and supply of Vaxelis. The company reports it won’t be available in the U.S. before 2020. A...


  • Immunomedics' cancer treatment fails to win accelerated approval from the FDA

    Immunomedics Inc said on Thursday the U.S. Food and Drug Administration declined to grant accelerated approval for its breast cancer treatment, sacituzumab.